Begin with the exact intervention
Before relying on an NAD+ study, identify the substance, formulation, route and participants. An oral precursor trial, an animal experiment and a human IV study ask different questions. A citation can be legitimate while still failing to support the specific commercial claim placed beside it.
Also identify the comparison group and duration. A change from baseline without a suitable comparator cannot isolate all competing explanations. The relevant question is not whether NAD+ biology is interesting, but whether the evidence supports the particular outcome being discussed for the preparation and population at hand.
What the small IV pilot measured
Grant and colleagues' 2019 pilot examined NAD-related compounds in blood and urine during an IV infusion. It included eight men receiving NAD+ and three saline controls. The study helps describe metabolism under that experimental protocol; it was not designed to establish longer lifespan or reliable cognitive improvement from a commercial wellness program.
The paper also discloses research and clinic-related financial relationships. Those disclosures do not automatically invalidate the work, but they belong in a careful reading alongside the small sample and limited endpoints. Independent replication and clinically meaningful outcomes would address different questions.
A precursor finding is not an injection finding
The 2021 Yoshino study investigated NMN in a selected group of postmenopausal women with prediabetes and reported a muscle insulin-sensitivity finding. That is a defined intervention, population and outcome. It should not be rewritten as proof that compounded NAD+ nasal spray improves cognition or that an IV service reverses aging.
Route and molecule differences are not minor footnotes when moving from a paper to a purchasing decision. Ask a provider to identify which evidence directly concerns the product offered and which supplies background rationale. Both can be discussed, but they should not be presented as the same level of support.
Testimonials and surveys answer narrower questions
A testimonial describes a person's reported experience. A customer survey can summarize responses from the people who participated. Neither alone demonstrates a causal drug effect, because expectations, selection, other treatments and changes in sleep or activity can influence what is reported.
Useful survey interpretation asks who responded, who did not, when questions were asked and whether the outcome was measured consistently. A high satisfaction percentage should not be converted into a probability that a new patient will experience the same result. A study of biomarkers should likewise not be promoted as a measured improvement in daily functioning.
Translate uncertainty into a better consultation
Discuss the actual symptom or goal, the available evidence, possible risks and how the clinician would assess whether continuing makes sense. Ask what alternatives or further evaluation are appropriate. This is more useful than demanding a guaranteed timetable for a benefit that has not been firmly established.
Our reviews compare public prices and services; they do not conduct clinical testing or certify treatment efficacy. Compounded products also lack FDA approval. Keeping that distinction visible allows a detailed commercial comparison without implying that a well-designed website, a named pharmacy or a higher price settles the underlying medical evidence.
Sources & further reading
Official pages and evidence consulted for this article. Checked October 11, 2026. Provider pages establish advertised terms; they do not independently establish effectiveness.
- Grant et al. 2019: Human plasma and urine metabolome during NAD+ IV infusion Clinical research
- Yoshino et al. 2021: NMN and muscle insulin sensitivity in prediabetic women Clinical research
- AgelessRx NAD+ Injection Provider
- AgelessRx NAD+ Nasal Spray Provider
- FDA: Compounding questions and answers Regulator